Robert Vendramelli

427 total citations
16 papers, 102 citations indexed

About

Robert Vendramelli is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Robert Vendramelli has authored 16 papers receiving a total of 102 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 8 papers in Epidemiology and 5 papers in Molecular Biology. Recurrent topics in Robert Vendramelli's work include SARS-CoV-2 and COVID-19 Research (6 papers), Viral Infections and Vectors (4 papers) and Viral Infections and Outbreaks Research (4 papers). Robert Vendramelli is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (6 papers), Viral Infections and Vectors (4 papers) and Viral Infections and Outbreaks Research (4 papers). Robert Vendramelli collaborates with scholars based in Canada, United States and United Kingdom. Robert Vendramelli's co-authors include Darwyn Kobasa, Angela Sloan, Nikesh Tailor, Bryce M. Warner, Kevin Tierney, Keding Cheng, Bryan D. Griffin, Mable Chan, J. David Knox and Anders Leung and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Virology and Journal of Clinical Microbiology.

In The Last Decade

Robert Vendramelli

14 papers receiving 102 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Vendramelli Canada 7 65 33 28 11 9 16 102
I. Abrrey Monreal United States 6 24 0.4× 39 1.2× 26 0.9× 11 1.0× 6 0.7× 9 70
Pierina Lorencini Parise Brazil 6 64 1.0× 20 0.6× 11 0.4× 9 0.8× 26 2.9× 14 95
Fawzi Derrar Algeria 4 57 0.9× 30 0.9× 22 0.8× 9 0.8× 5 0.6× 7 93
Uriel Ortega‐Rodriguez United States 5 75 1.2× 18 0.5× 47 1.7× 11 1.0× 17 1.9× 12 126
Krithika Muthuraman Canada 5 70 1.1× 17 0.5× 36 1.3× 17 1.5× 5 0.6× 6 103
Rebekah Penrice-Randal United Kingdom 5 99 1.5× 15 0.5× 37 1.3× 12 1.1× 3 0.3× 11 117
Nathan Moore United Kingdom 4 34 0.5× 20 0.6× 21 0.8× 5 0.5× 8 0.9× 4 76
Grégory Quéromès France 5 73 1.1× 14 0.4× 42 1.5× 15 1.4× 4 0.4× 6 110
Fengze Wang China 4 72 1.1× 18 0.5× 37 1.3× 17 1.5× 4 0.4× 7 96
Anastasija Čupić United States 4 82 1.3× 22 0.7× 22 0.8× 31 2.8× 2 0.2× 9 103

Countries citing papers authored by Robert Vendramelli

Since Specialization
Citations

This map shows the geographic impact of Robert Vendramelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Vendramelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Vendramelli more than expected).

Fields of papers citing papers by Robert Vendramelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Vendramelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Vendramelli. The network helps show where Robert Vendramelli may publish in the future.

Co-authorship network of co-authors of Robert Vendramelli

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Vendramelli. A scholar is included among the top collaborators of Robert Vendramelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Vendramelli. Robert Vendramelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Vendramelli, Robert, Thang Truong, Trushar Jeevan, et al.. (2025). Highly pathogenic avian influenza H5N1 clade 2.3.4.4b hemagglutinin and/or neuraminidase elicit immunity in a recombinant nanoparticle vaccine. 1(5). 100070–100070. 1 indexed citations
2.
Prévost, Jérémie, Nikesh Tailor, Geoff Soule, et al.. (2025). CD4+ and CD8+ T cells are not the main driver of Lassa fever pathogenesis in macaques. JCI Insight. 10(22).
3.
Warner, Bryce M., Jonathan Audet, Douglas C. Barker, et al.. (2024). Delayed treatment of cynomolgus macaques with a FVM04/CA45 monoclonal antibody cocktail provides complete protection against lethal Sudan virus infection. Journal of Virology. 98(8). e0124223–e0124223.
4.
Warner, Bryce M., Robert Vendramelli, Thang Truong, et al.. (2024). Intranasal vaccination with an NDV-vectored SARS-CoV-2 vaccine protects against Delta and Omicron challenges. npj Vaccines. 9(1). 90–90. 6 indexed citations
5.
Boese, Amrit S., Bryce M. Warner, Peter McQueen, et al.. (2024). SARS-CoV-2 infection results in a unique lung proteome long after virus resolution in the hamster. SHILAP Revista de lepidopterología. 2(1). 40–40. 2 indexed citations
6.
Truong, Thang, Bryce M. Warner, Robert Vendramelli, et al.. (2023). Cell-Free Dot Blot: an Ultra-Low-Cost and Practical Immunoassay Platform for Detection of Anti-SARS-CoV-2 Antibodies in Human and Animal Sera. Microbiology Spectrum. 11(2). e0245722–e0245722. 3 indexed citations
7.
Vendramelli, Robert, Angela Sloan, Nikesh Tailor, et al.. (2023). The Nucleocapsid Proteins of SARS-CoV-2 and Its Close Relative Bat Coronavirus RaTG13 Are Capable of Inhibiting PKR- and RNase L-Mediated Antiviral Pathways. Microbiology Spectrum. 11(3). e0099423–e0099423. 7 indexed citations
8.
Deschambault, Yvon, Bryce M. Warner, Kevin Tierney, et al.. (2022). Single Immunization with Recombinant ACAM2000 Vaccinia Viruses Expressing the Spike and the Nucleocapsid Proteins Protects Hamsters against SARS-CoV-2-Caused Clinical Disease. Journal of Virology. 96(9). e0038922–e0038922. 8 indexed citations
9.
Ao, Zhujun, Maggie Jing Ouyang, Bryce M. Warner, et al.. (2022). A Recombinant VSV-Based Bivalent Vaccine Effectively Protects against Both SARS-CoV-2 and Influenza A Virus Infection. Journal of Virology. 96(18). e0133722–e0133722. 19 indexed citations
10.
Tailor, Nikesh, Bryce M. Warner, Bryan D. Griffin, et al.. (2022). Generation and Characterization of a SARS-CoV-2-Susceptible Mouse Model Using Adeno-Associated Virus (AAV6.2FF)-Mediated Respiratory Delivery of the Human ACE2 Gene. Viruses. 15(1). 85–85. 7 indexed citations
11.
Chan, Mable, Helen L. Wu, Nikesh Tailor, et al.. (2022). Pandemic 1918 Influenza Virus Does Not Cause Lethal Infection in Rhesus or Cynomolgus Macaques. Journal of Virology. 96(16). e0072822–e0072822. 4 indexed citations
12.
Chan, Mable, Anders Leung, Tamiko Hisanaga, et al.. (2020). H7N9 Influenza Virus Containing a Polybasic HA Cleavage Site Requires Minimal Host Adaptation to Obtain a Highly Pathogenic Disease Phenotype in Mice. Viruses. 12(1). 65–65. 7 indexed citations
13.
Mendoza, Emelissa J., Kimberly R. Holloway, Kristina Dimitrova, et al.. (2019). Establishment of a comprehensive and high throughput serological algorithm for Zika virus diagnostic testing. Diagnostic Microbiology and Infectious Disease. 94(2). 140–146. 4 indexed citations
14.
Chan, Mable, Anders Leung, Bryan D. Griffin, et al.. (2019). Generation and Characterization of a Mouse-Adapted Makona Variant of Ebola Virus. Viruses. 11(11). 987–987. 14 indexed citations
15.
Cheng, Keding, Angela Sloan, Robert Vendramelli, et al.. (2017). Altered rPrP substrate structures and their influence on real-time quaking induced conversion reactions. Protein Expression and Purification. 143. 20–27. 3 indexed citations
16.
Cheng, Keding, et al.. (2016). Endpoint Quaking-Induced Conversion: a Sensitive, Specific, and High-Throughput Method for Antemortem Diagnosis of Creutzfeldt-Jacob Disease. Journal of Clinical Microbiology. 54(7). 1751–1754. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026